Mankind is in an arms race with drug-resistant pathogens. This book reveals how benign bacteria become pathogenic by acquiring new genes and proposes a third strategy beyond drugs and vaccines: achieving herd resistance by enhancing our protective intestinal microbiota.
Shu-Lin Liu
Dr Shu-Lin Liu is affiliated with Harbin Medical University, China, and the University of Calgary, Canada. His career with microbes began in 1971 at the clinical laboratory of Fujin Central Hospital, China, and he conducted his PhD studies from 1985 to 1990 at Gifu University, Japan. His publications include 160 original papers and 16 books and book chapters in English, Chinese or Japanese, while his research is mostly concerned with microbes, with Salmonella as primary models for genomic evolution and pathogenesis studies.
Author's books
View more
This product has multiple variants. The options may be chosen on the product page
From £35.99
View more
This product has multiple variants. The options may be chosen on the product page